Effectiveness of mindfulness-based cognitive therapy separately and combined with TDCS (device treatment) on Worry, Emotion regulation, Pain severity and quality of life in Chronic muscle pain patients.

Effectiveness of mindfulness-based cognitive therapy separately and combined with TDCS on Worry, Emotion regulation, Pain severity and quality of life in Fibromyalgia patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201004048920N1

Enrollment

Registered

2020-11-18

Start date

2020-10-11

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia. Fibromyalgia

Interventions

Intervention 1: Intervention group: Mindfulness-Based Cognitive Therapy (MBCT): Accomplished in groups of 12 people in 2 hours sessions per week. (2 sessions per week) during 1 month on 12 patients. T

Eligibility

Sex/Gender

All

Age

30 Years to 55 Years

Inclusion criteria

Inclusion criteria: Fibromyalgia disorder. Pain period: at least 6 months. Pain is not related to another disease such as cancer or MS. Ability to attend treatment sessions and not attended in any psychological treatment program during last 6 months

Exclusion criteria

Exclusion criteria: suffering from a Rheumatologic or acute psychological disorder which lead to pain. have past epilepsy, seizure disease, Traumatic Brain Injury, brain tumor and brain implant and Mental retardation. Acute heart patients using drug pump. Pregnant people. Substance abuse and addicted patients.

Design outcomes

Primary

Measure	Time frame
Worry. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Pennsylvania State Worry Questionnaire.;Emotion regulation. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Cognitive Emotion Regulation Questionnaire.;Pain severity. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Short-form McGill Pain Questionnaire.;Quality of life. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Short-Form 36 (SF-36) questionnaire.	—

Measure

Time frame

Worry. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Pennsylvania State Worry Questionnaire.;Emotion regulation. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Cognitive Emotion Regulation Questionnaire.;Pain severity. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Short-form McGill Pain Questionnaire.;Quality of life. Timepoint: Before treatment, Maximum a week after treatment, two months after treatment. Method of measurement: Short-Form 36 (SF-36) questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Akbarzadeh

The University of Semnan

m_akbarzadeh66@yahoo.com+98 23 3362 4250

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026